A trial drug called APN01 or human recombinant soluble ACE2 (hrsACE2) can significantly block early stages of SARS-CoV-2 infections, according to a paper published in the journal Cell.
Experimental Drug Blocks Growth of SARS-CoV-2 Coronavirus in Cell Cultures and Organoids
Posted in biotech/medical